Scope of the Journal

Clinical Biomedical Communications (CBC) seeks to bridge basic, translational, and clinical research by publishing work that clearly articulates its implications for patient care, population health, and health systems, while ensuring that authors receive timely editorial decisions and accelerated online publication.

The journal also aims to improve the clarity and accessibility of scientific writing, supporting concise, well-structured manuscripts that can be rapidly reviewed, understood, and applied by clinicians, researchers, and policymakers worldwide.

CBC welcomes manuscripts that advance knowledge at the interface of clinical medicine and biomedical science, with a strong emphasis on studies that can benefit from a rapid and streamlined review and publication process.

The journal publishes original research articles, brief reports and fast-track communications, clinical trials, translational and experimental studies, systematic reviews and meta-analyses, high-quality case reports and series, methodological and educational papers, and focused perspectives or commentaries.

Core subject areas include, but are not limited to:

• Clinical research across all medical and surgical specialties, including observational and interventional studies suited for rapid dissemination.

• Translational and experimental medicine linking mechanistic insights to diagnostics, prognostics, or therapies, where fast communication can accelerate clinical impact.

• Clinically relevant biomedical sciences, such as molecular and cellular mechanisms of disease, immunology, genetics and genomics, pharmacology, and biomarker research.

• Public health and epidemiology with clear clinical or policy implications that benefit from the timely availability of evidence.

• Diagnostics, therapeutics, devices, and medical technologies, including precision medicine, digital health, and decision-support tools requiring fast visibility to end-users.

• Health services research, implementation science, and quality-improvement projects where rapid feedback and dissemination can directly inform practice.

The journal is particularly interested in:

• Studies that clarify disease mechanisms, treatment response, or safety signals and that require rapid review and publication to inform clinical practice.

• Research that improves communication between patients and providers or multidisciplinary teams, including tools and interventions designed for practical, fast uptake.

• Work addressing equity, access, and context-specific solutions, especially in low- and middle-income settings, where rapid access to new evidence can change practice.

• Methodological and reporting innovations that enhance transparency, reproducibility, and efficient evaluation, enabling a consistently fast and high-quality peer-review process.

The journal accepts several categories of manuscripts.

Original Research Articles

Comprehensive reports of high-impact, novel translational studies.

Mini-Review Articles

Authoritative, critical, timely, and focused syntheses of the current literature in a specific area of molecular or clinical biomedicine.

Brief Case Report

A concise report of research or clinical case, including the presentation of research that extends previously published research, the reporting of additional data and confirmatory results, and small-scale studies.

Short Communications

Concise discussions offering forward-looking viewpoints or commentary on significant recent advancements.

Methods and Protocols

Detailed descriptions of novel techniques or significantly improved methodologies with broad applicability in the field.

Letters to the Editor

Brief, critical comments on previously published articles or reports of limited, but highly important, data.